Home / Database / Top Companies / Johnson & Johnson

Johnson & Johnson

Rank #42 on Forbes Global 2000 — View on Forbes

Company Profile

Johnson & Johnson

Drugs & Biotechnology

http://www.jnj.com

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Country

United States

Headquarters

New Brunswick, New Jersey

CEO

Joaquin Duato

Industry

Drugs & Biotechnology

Employees

138,100

Revenue

$89,331M

Profits

$21,810M

Assets

$193,671M

Founded

1886

وثائق الحوكمة مسئولیت اجتماعی و حقوق بشر

Position on Employee Development and Total Health and Well-being

مسئولیت اجتماعی و حقوق بشر

Johnson & Johnson

Johnson & Johnson

Position on Employee Development and Total Health and Well-being

Position on Human Rights

Responsibility Standards for Suppliers

Lobbying Disclosure Report

Position on Pharmaceuticals in the Environment

Position on the Conduct of Clinical Trials

Position on Employment and Labor Rights

Position on Providing a Safe and Harassment-Free Workplace

Position on Providing a Discrimination-Free Workplace

Environmental Stewardship Position

Position on Resolving Employee Grievances

Position on Climate and Health

Position on Ethical Sales and Marketing

Position on Climate and Health

2024

Business Continuity Management Position

2024 Patient Access and Drug Pricing Issue Brief

2024 CDP Corporate Questionnaire

2024 Health for Humanity Report

2024 Health for Humanity Report

2024 Health for Humanity Report Environmental Data Assurance

Animal Welfare Policy

Position on Clinical Trial Data Transparency

Position on ESG Governance

Disaster Relief Position Statement

Climate Action at a Glance

Anti-Corruption Position Statement

Principles of Corporate Governance

Position on Counterfeit Healthcare Products

Conflict Minerals Position Statement

Environmental Health & Safety Management Position

Position on Responsible Chemical Management

Enterprise Risk Management Framework

Ethical Use of Artificial Intelligence

Position on Data Privacy

Health for Humanity Report

Position on Responsible Interaction with Healthcare Professionals

Position on Community Impact

Position on Supporting the United Nations Sustainable Development Goals

2022 Health for Humanity Report

Position on Human Pluripotent Stem Cell Research

2021 Health for Humanity Report

Employment of Young Persons Policy

2020 Health for Humanity Report

Ethical Code for the Conduct of Research and Development

Position on Bioethics

Procurement Code of Conduct

Procurement Code of Conduct

2016 Annual Report

2012 Citizenship & Sustainability Report

2011 Responsibility Report

2010 Responsibility Report

Sustainability Report 2008

2007 Sustainability Report

Regulatory Compliance & Sustainability Committee Charter

Report of Independent Accountants and Management's Assertion

Transparency Report: Patient Access and Affordability

Code of Business Conduct

Global Health Equity

Empowering Nurse-Led Innovation to Transform Health